MedTrace Logo

Sepsis and Thiol-Disulfide Balance in Emergency Department

NCT07134868 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2025-08-21

No results posted yet for this study

Summary

The aim of this study was to determine the effectiveness of thiol-disulfide homeostasis in predicting diagnosis and mortality in sepsis patients, and to compare it with other inflammatory markers.

Conditions

Interventions

DIAGNOSTIC_TEST

Thiol- Disulfide Blood Sample Measurement

Measurement of thiol-disulfide homeostasis parameters and inflammatory markers from serum samples.

Sponsors & Collaborators

  • Sakarya University

    lead OTHER

Principal Investigators

  • Mehmet Alacam, M.D. · Sakarya University

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-06-15
Primary Completion
2018-09-30
Completion
2018-12-15

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07134868 on ClinicalTrials.gov